Regression of Abdominal Aortic Aneurysms by Simultaneous Inhibition of Nuclear Factor &kgr;B and Ets in a Rabbit Model

Because current therapy to treat abdominal aortic aneurysm (AAA), and particularly to manage small AAA, is limited to elective surgical repair, we explored less invasive molecular therapy by simultaneous inhibition of the transcription factors nuclear factor (NF)&kgr;B and ets using a decoy strategy. Both NF&kgr;B and ets were shown to be markedly activated in human AAA. In addition, NF&kgr;B- and ets-positive cells were increased in the aneurysm wall, and a part of the expression of NF&kgr;B and ets was detected in migrating macrophages. Thus, we used chimeric decoy oligodeoxynucleotides (ODNs) containing consensus sequences of both NF&kgr;B and ets binding sites to treat AAA. Inhibitory effects of chimeric decoy ODNs on matrix metalloproteinase-1 and -9 expression were confirmed by ex vivo experiments using a human aorta organ culture. To examine the regressive effect in a rabbit already-formed AAA model, transfection by wrapping a delivery sheet containing chimeric decoy ODNs around the aneurysm was performed 1 week after incubation with elastase. Importantly, treatment with chimeric decoy ODNs significantly decreased the size of AAA. Interestingly, significant preservation of elastic fibers was observed with chimeric decoy ODN treatment, accompanied by a reduction of matrix metalloproteinase-2 and -9 and induction of macrophage apoptosis. Regression of AAA was also associated with an increase in elastin and collagen type I and III synthesis in the aneurysm wall. Minimally invasive molecular therapy targeted to the inhibition of NF&kgr;B and ets is expected to be useful for AAA through the rebalance of matrix synthesis and degradation.

[1]  M. Aoki,et al.  Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFκB and ets using chimeric decoy oligonucleotides in a rabbit model , 2006, Gene Therapy.

[2]  R. Ricci,et al.  Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.

[3]  M. Aoki,et al.  Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model , 2005, Gene Therapy.

[4]  E. Mezey,et al.  Identification of a Novel NF-κB-binding Site with Regulation of the Murine α2(I) Collagen Promoter* , 2004, Journal of Biological Chemistry.

[5]  H. Bergmeister,et al.  Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. , 2004, Blood.

[6]  M. Aoki,et al.  Inhibition of Experimental Abdominal Aortic Aneurysm in the Rat by Use of Decoy Oligodeoxynucleotides Suppressing Activity of Nuclear Factor &kgr;B and ets Transcription Factors , 2003, Circulation.

[7]  J. Horowitz,et al.  Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects. , 2002, American journal of physiology. Endocrinology and metabolism.

[8]  J. Foster,et al.  NF-κB induced by IL-1β inhibits elastin transcription and myofibroblast phenotype , 2002 .

[9]  V. Sementchenko,et al.  Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β* , 2002, The Journal of Biological Chemistry.

[10]  C. Frank,et al.  ACL transection influences mRNA levels for collagen type I and TNF‐α in MCL scar , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  M. Karin,et al.  Inhibition of JNK activation through NF-κB target genes , 2001, Nature.

[12]  M. Thompson,et al.  Ubiquitous Elevation of Matrix Metalloproteinase-2 Expression in the Vasculature of Patients With Abdominal Aneurysms , 2001, Circulation.

[13]  M Shiomi,et al.  Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits , 2001, Circulation.

[14]  P. Shah,et al.  Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization , 2001, Circulation.

[15]  H. Perlman,et al.  Macrophages Require Constitutive NF-κB Activation To Maintain A1 Expression and Mitochondrial Homeostasis , 2000, Molecular and Cellular Biology.

[16]  Y. Soini,et al.  Increased amount of type III pN-collagen in human abdominal aortic aneurysms: evidence for impaired type III collagen fibrillogenesis. , 2000, Journal of vascular surgery.

[17]  G. Koh,et al.  Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. , 2000, Biochemical and biophysical research communications.

[18]  A. Baker,et al.  Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. , 1999, Biochemical and biophysical research communications.

[19]  D. Brenner,et al.  NF-kappaB inhibits expression of the alpha1(I) collagen gene. , 1999, DNA and cell biology.

[20]  Hiroki Sato,et al.  Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 , 1999, Journal of Virology.

[21]  J. Uitto,et al.  Nuclear Factor-κB Mediates TNF-α Inhibitory Effect on α2(I) Collagen (COL1A2) Gene Transcription in Human Dermal Fibroblasts , 1999, The Journal of Immunology.

[22]  B. Starcher,et al.  Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). , 1999, Journal of vascular surgery.

[23]  K. Fujikawa,et al.  The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor , 1998, International journal of cancer.

[24]  D. Carey,et al.  Expression of Matrix Metalloproteinases and TIMPs in Human Abdominal Aortic Aneurysms , 1998, Annals of vascular surgery.

[25]  J. Boyle,et al.  Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. , 1998, Journal of vascular surgery.

[26]  W. Pearce,et al.  Size matters: the relationship between MMP-9 expression and aortic diameter. , 1997, Circulation.

[27]  P. Shah,et al.  Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. , 1997, Circulation.

[28]  M. Malim,et al.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R W Thompson,et al.  Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. , 1996, Current opinion in cardiology.

[30]  E. Lengyel,et al.  Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.

[31]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[32]  T. Juvonen,et al.  Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. , 1995, Journal of Vascular Surgery.

[33]  R. Mecham,et al.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.

[34]  P. Dobrin,et al.  Failure of Elastin or Collagen as Possible Critical Connective Tissue Alterations Underlying Aneurysmal Dilatation , 1994, Cardiovascular surgery.

[35]  J. Rosenbloom,et al.  Tumor necrosis factor-alpha down-regulates human elastin gene expression. Evidence for the role of AP-1 in the suppression of promoter activity. , 1992, The Journal of biological chemistry.

[36]  J. Casasnovas,et al.  The effect of the simple repeating d(CG.GC)n, d(CA.GT)n, and d(A.T)n DNA sequences on the nucleosomal organization of SV40 minichromosomes. , 1991, DNA and cell biology.

[37]  R. Pierce,et al.  Collagen and elastin metabolism in hypertensive pulmonary arteries of rats. , 1990, Circulation research.

[38]  E. Mezey,et al.  Identification of a novel NF-kappaB-binding site with regulation of the murine alpha2(I) collagen promoter. , 2004, The Journal of biological chemistry.

[39]  V. Sementchenko,et al.  Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. , 2002, The Journal of biological chemistry.

[40]  J. Foster,et al.  NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype. , 2002, American journal of physiology. Cell physiology.

[41]  C. Frank,et al.  ACL transection influences mRNA levels for collagen type I and TNF-alpha in MCL scar. , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[42]  M. Karin,et al.  Inhibition of JNK activation through NF-kappaB target genes. , 2001, Nature.

[43]  T. Major,et al.  The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[44]  J. Uitto,et al.  Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. , 1999, Journal of immunology.

[45]  G. Snider,et al.  Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[46]  B. Vandenbunder,et al.  Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion? , 1994, Folia biologica.